phosphoserine has been researched along with Migraine with Aura in 1 studies
Phosphoserine: The phosphoric acid ester of serine.
Migraine with Aura: A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nair, A | 1 |
| Simonetti, M | 1 |
| Birsa, N | 1 |
| Ferrari, MD | 1 |
| van den Maagdenberg, AM | 1 |
| Giniatullin, R | 1 |
| Nistri, A | 1 |
| Fabbretti, E | 1 |
1 other study available for phosphoserine and Migraine with Aura
| Article | Year |
|---|---|
Familial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain.
Topics: Adenosine Triphosphate; Agatoxins; Amino Acid Substitution; Animals; Calcineurin; Calcium Channels, | 2010 |